Table 1 Study characteristics (N = 65)
From: Health-related quality of life in Hodgkin lymphoma: a systematic review
Study design, n (%) | |
|---|---|
 Comparator: RCT | 3 (5) |
 Comparator: cohort | 14 (22) |
 Cohort | 45 (69) |
 Comparator: case control | 3 (5) |
Study type, n (%) | |
 Longitudinal | 12 (18) |
 Cross-sectional | 53 (82) |
Study setting, n (%) | |
 In person | 18 (28) |
 Remote | 42 (65) |
 NS | 5 (8) |
Decade of publication | |
 Before 1995 | 6 (9) |
 1995 to 2004 | 25 (38) |
 2005 to June 2015 | 34 (52) |
Study sponsor, n (%) | |
 Cooperative group | 7 (11) |
 Investigator initiated | 58 (89) |
Geographic location, n (%) | |
 USA | 19 (29) |
 Norway | 17 (26) |
 Netherlands | 7 (11) |
 Germany | 4 (6) |
 Other Europe | 10 (15) |
 South America | 4 (6) |
 Canada | 3 (5) |
 Asia | 1 (2) |
n (HL patients) | |
 Median (range) | 132 (12–3208) |
 25–75th percentile | 58–280 |
Treatment status, n (%) | Â |
 Active and off treatment | 6 (9) |
 Off treatment only | 59 (91) |
Agea | |
 Mean (n = 33) | 39.6 |
 Median (n = 21) | 38 |
Gender, % | |
 Female (n = 54) | 44.0 % |
 Range | 0–100 % |